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Abstract
Background: Ablation of TRPV1-expressing nociceptive fibers with the potent capsaicin analog resiniferatoxin (RTX)
results in long lasting pain relief. RTX is particularly adaptable to focal application, and the induced chemical
axonopathy leads to analgesia with a duration that is influenced by dose, route of administration, and the rate of
fiber regeneration. TRPV1 is expressed in a subpopulation of unmyelinated C- and lightly myelinated Adelta fibers
that detect changes in skin temperature at low and high rates of noxious heating, respectively. Here we investigate
fiber-type specific behaviors, their time course of recovery and molecular correlates of axon damage and
nociception using infrared laser stimuli following an RTX-induced peripheral axonopathy.
Results: RTX was injected into rat hind paws (mid-plantar) to produce thermal hypoalgesia. An infrared diode laser
was used to stimulate Adelta fibers in the paw with a small-diameter (1.6 mm), high-energy, 100 msec pulse, or C-
fibers with a wide-diameter (5 mm), long-duration, low-energy pulse. We monitored behavioral responses to indicate
loss and regeneration of fibers. At the site of injection, responses to C-fiber stimuli were significantly attenuated for
two weeks after 5 or 50 ng RTX. Responses to Adelta stimuli were significantly attenuated for two weeks at the
highest intensity stimulus, and for 5 weeks to a less intense Adelta stimulus. Stimulation on the toe, a site distal to
the injection, showed significant attenuation of Adelta responses for 7- 8 weeks after 5 ng, or 9-10 weeks after 50 ng
RTX. In contrast, responses to C-fiber stimuli exhibited basically normal responses at 5 weeks after RTX. During the
period of fiber loss and recovery, molecular markers for nerve regeneration (ATF3 and galanin) are upregulated in the
dorsal root ganglia (DRG) when behavior is maximally attenuated, but markers of nociceptive activity (c-Fos in spinal
cord and MCP-1 in DRG), although induced immediately after RTX treatment, returned to normal.
Conclusion: Behavioral recovery following peripheral RTX treatment is linked to regeneration of TRPV1-expressing
Adelta and C-fibers and sustained expression of molecular markers. Infrared laser stimulation is a potentially
valuable tool for evaluating the behavioral role of Adelta fibers in pain and pain control.
Background
TRPV1 is a sodium/calcium ion channel expressed in a
subpopulation of DRG neurons that respond to noxious
heat, endogenous algesic compounds, and the vanilloid
agonist capsaicin [1-3]. Capsaicin responses are detected
in subpopulations of unmyelinated C-fiber neurons and
myelinated Aδ-fibers [4,5]. Electrophysiological studies
with radiant heat have shown that thermal sensing
C-fibers mediate responses to stimuli that heat the skin
at low rates (≤ 0.9°C/sec) whereas Aδ-fibers mediate
responses to stimuli that heat the skin at high rates
(≥ 6.5°C/sec) [6]. TRPV1 in C-fibers is responsible for
burning pain sensations plus the integration of inflam-
matory chemical signals in many pathological pain
states, and multiple drug development efforts have been
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TRPV1 agonists, such as the ultrapotent capsaicin analo-
gue resiniferatoxin (RTX), have also been proposed as
therapeutic agents for treating acute and chronic pain
[10,11]. The binding of RTX leads to a sustained influx
of sodium and calcium through TRPV1 channels [12]
leading to channel desensitization and/or the loss of
TRPV1-expressing DRG neurons and/or their fibers and
terminals via calcium-induced cytotoxicity [13,14]. Thus,
although the mechanisms diverge, ultimately either ago-
nists or antagonists can be used as analgesic agents.
While antagonists can be administered orally, for ago-
nists local administration is required and the route or
site of administration is a critical factor. For example,
RTX injection into the intrathecal space results in a loss
of centrally projecting TRPV1-expressing fibers in the
dorsal roots and at higher concentrations a loss of
TRPV1-expressing DRG neuronal perikarya; both cases
produce permanent regional analgesia [14-16]. In con-
trast, injections of low concentrations of RTX into per-
ipheral sites (e.g., subcutaneous injections) spare the
neuronal perikarya while ablating or temporarily inacti-
vating TRPV1-expressing peripheral terminals and fibers
[17,18]. This approach therefore results in temporary
analgesia at focal sites until the fibers reactivate or
regenerate. Systemic injections of RTX have also been
used to induce analgesia; however, higher concentrations
of RTX are needed and the analgesic effect is wide-
spread rather than regional or focal [19].
Although TRPV1 is expressed in C- and Aδ-fibers,
most animal studies that have ablated TRPV1 fibers with
capsaicin or RTX focus on behavioral responses asso-
ciated with C-fibers [14,17,20,21]. This can be attributed,
primarily, to the prevalence of thermal pain assays that
examine C-fibers rather than Aδ-fibers in awake rodents.
Indeed, in the rat, where the axons are relatively short
(20 cm or less), it may be difficult to distinguish beha-
vioral responses mediated solely by fast-conducting Aδ-
fibers. For example, the conduction velocity of the rela-
tively slower C-fibers is sufficient enough to produce
laser evoked potentials (LEP) as early as 225 ms after
heating the paw with a brief CO2 laser pulse [22].
One goal of this study was to evaluate the usage of an
infrared diode laser to examine behavioral responses
that are discretely associated with Aδ activation in the
rat. Infrared diode lasers, in contrast to CO2 lasers, are
capable of directly heating the skin at depths where
cutaneous nerve fibers terminate, thereby providing
rapid (capable of > 200°C/sec), efficient, non-damaging
thermal stimulation of Aδ-fibers [23-25], which can also
initiate rapid behavioral responses. We combined RTX-
induced ablation of TRPV1 fibers in plantar hind paw
[17] with infrared laser stimulation and provide an
excellent model to examine the contribution of
Aδ-fibers to nociceptive behaviors in rats. Our findings
demonstrate that RTX-induced thermal hypoalgesia is
sustained longer than previously thought, and RTX
greatly attenuates behavioral responses characteristic of
Aδ stimulation. Importantly, this methodology suggests
infrared laser stimuli can be used to analyze behavior
associated with fast-conducting Aδ-fibers, which has
been relatively difficult to accomplish in awake, unrest-
rained rodents.
Results
We sought to specifically stimulate afferent nerve fiber
subtypes in the glabrous skin of the rat hind paw using
either short-pulse, high-rate (Aδ) or long-pulse, low-rate
(C) skin heating with an infrared diode laser. Studies in
rats have suggested that withdrawal activity following
short-duration, high-intensity stimulation of the hind
paw with a CO2 laser is mediated by C-rather than Aδ-
fibers, in part from recordings of electromyographic
(EMG) activity in the stimulated limb [26] and/or of
laser-evoked cortical potentials (LEPs) [22,27,28], that
show latencies consistent with a conduction velocity in
the C-fiber range. The infrared diode laser used here
has the ability to specifically activate Aδ fibers, which
has been determined from direct extracellular recordings
of trigeminal ganglion neurons in rats [25]. In order to
further establish a relationship between Aδ conduction
and nociceptive response a high-speed video camera
(500 fps) was used to record stimulation-induced move-
ments in awake, freely-moving rats during the brief peri-
stimulus time period.
With the high-speed camera we observed that the actual
withdrawal of the stimulated limb was often preceded by a
panoply of dedicated motor programs. For example, video
frames of a rat before, and in the first 300 msec after sti-
m u l a t i o n( 6 . 0 8W / m m 2 )a r es h o w ni nF i g u r e1 .I nt h i s
example, visible head movement towards the stimulated
hind paw could be detected by 110 msec. The right eye
was also seen to squeeze shut by 110 msec, however, this
behavior was not a prominent feature in many of the trials.
Figure 1C illustrates that by 210 ms, the stimulated toe has
been retracted off the glass platform, and by 310 ms with-
drawal of the hind limb is fully apparent (Figure 1D). The
latency from the noxious phase (the period after the first
30 ms from when the laser stimulation began, see Meth-
ods) of the stimulus to the first observable laser-evoked
movement (fLEM) in this trial was 74 ms which occurred
in a forelimb rather than the stimulated limb (see also
Additional file 1 Movie S1). In contrast, the latency to
fLEM in the stimulated limb was 112 msec. Nerve length
from the toe to the dorsal root entry zone was 16.8 cm,
based on dissection (350 g rat). Hence, this example
suggests a minimum conduction velocity of 2.27 m/s
(0.168 m/0.074 s), which is well within the range for
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TRPV1 population of C-fibers [~0.4 m/s] [31].
Calculated estimates of conduction velocity based on
latency to fLEM for a series of normal rats are listed in
Table 1. We observed that response latency appeared
highly dependent on the rat’s posture at the moment of
stimulation. From 16 video recorded trials, 6 of the 8
shortest latencies (n = 4 rats) to fLEM occurred when
body weight was not supported by all four limbs. In these
cases, one or both forepaws were not on the floor and
hence the rat was in the “reared” position prior to stimu-
lation. For these 16 trials, the shortest latency to fLEM
w a s5 6m sa n dt h ea v e r a g ew a s1 5 9 . 5±3 6 . 7m s e c .I n
contrast, 6 of the 8 longest latencies to fLEM occurred
when weight was distributed to all four paws; from these
trials, the shortest latency was 74 ms and the average was
250.0 ± 28.9 msec. It should be emphasized that our con-
duction velocity estimates are conservative. They do not
account for central delay (possibly as high as 80 ms
in the rat) [32], motoneuron conduction velocity
(33-85 m/s) [33] or the time required for muscle contrac-
tion/relaxation (34-116 ms) [33], which would necessarily
yield faster conduction velocity estimates. Furthermore,
the cascade of bilateral extensor/flexor muscle activity
required for abrupt postural adjustment is complex, and
the possibility is strong that the earliest muscle twitches
in some trials may have been missed entirely by the view-
ing angle of the camera. We cannot predict, at present,
where movement will occur first. Despite this, we could
capture in 31% of trials movements associated with nerve
conduction velocities higher than 1.7 m/s, clearly within
the range for Aδ-fibers, following a short, intense noxious
laser stimulus. We conclude that Aδ-fibers must be
recruited in some, if not all, responses under this stimu-
lus paradigm.
Rats were treated with intraplantar injection of 5 or 50
ng RTX and examined behaviorally over several weeks.
Two stimulus intensities were used to examine the
effect of RTX on Aδ-fiber activity. At baseline, the prob-
ability of withdrawal to the lower power stimulus (5.12
W/mm
2) was 0.69 ± 0.08 and the severity of withdrawal
(on the behavioral rating scale, see Methods) was 2.61 ±
0.24 (Figure 2A and 2B). After RTX injection, the prob-
ability of withdrawal and the severity of withdrawal were
eliminated or barely detectable during the first two
weeks. The 50 ng RTX-treated paws remained signifi-
cantly suppressed for up to 5 weeks. By week 7, there
was no longer a significant difference in behavioral
responses to the Aδ stimulus between the RTX and
vehicle treated paws. A statistically significant difference
was observed between the 5 and 50 ng doses over the
course of the study (p < 0.01, probability of withdrawal,
Figure 2A; p < 0.001, intensity of withdrawal, Figure 2B).
When stimulating with higher power (6.08 W/mm
2),
the probability of withdrawal and intensity of withdrawal
were close to maximum at baseline (0.92 ± 0.05 and
3.33 ± 0.19, Figure 2C and 2D, respectively). The stron-
ger behavioral responses with the 6.08 W/mm
2 stimulus
indicate more efficient heating of the skin as compared
to the 5.12 W/mm
2 stimulus. After 50 ng RTX, rats
were almost completely unresponsive to the 6.08 W/
mm
2 Aδ stimulus for the first two weeks. By three
weeks there was a substantial return towards baseline,
nonetheless, a small but significant difference could be
detected up to week 5 suggesting a small deficit in fiber
function remained. By week 7, there was no difference
A B
Before 110 ms
C D
Before 110 ms
210 ms 310 ms
F E F E
110 ms Before
Figure 1 Detection of early-onset nocifensive behaviors prior
to withdrawal of stimulated limb. A 100 msec thermal pulse at
high power (6.08 W/mm
2) was used to stimulate the right index
toe. Withdrawal responses were recorded at a rate of 500 frames
per second. The position of the rat’s head before and after
stimulation are highlighted in A and B, respectively. The upper and
lower arrowheads in each frame bring attention to the eyes and
nose, respectively. Abrupt head displacement in (A) versus (B)
occurs by 110 msec (140-30 msec, see Methods). Also note in B the
orbital “tightening”, which was observed only with some rats
following laser stimulation. (C) By 210 msec, the head was oriented
towards the stimulated foot and toes on the stimulated foot have
moved. (D) Withdrawal of the stimulated paw was underway by 310
msec. (E) and (F) are magnifications of (A) and (B), respectively,
showing that by 110 msec, toe movement on the non-stimulated
hind paw has preceded any movement detected in the stimulated
limb. Full videos can be viewed in the Additional file 1 Movie S1
data and show that latency to the first detectable movement was
approximately 74 msec.
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5.12 W/mm
2 setting. Responses from the 5 ng RTX
treated paws returned to baseline levels by week 3. As
with the lower power setting, a statistical difference
between the 5 and 50 ng groups was observed when sti-
mulating with the 6.08 W/mm
2 laser pulse (p < 0.01,
probability of withdrawal, Figure 2C; p < 0.05, intensity
of withdrawal, Figure 2D).
Our previous work demonstrated that 62.5 ng of RTX
attenuates C-fiber responses for about 2 weeks [17]. In
the present study, normal rats withdrew from the laser
generated C-fiber stimulus at about 8 s (Figure 2E). In
rats lightly anesthetized with 0.5% isoflurane, a withdra-
wal response is retained, and the skin temperature (sti-
mulation site) at the time of withdrawal was 48.5 ± 0.5°
C when measured using a thermal camera [data not
shown]. Both doses of RTX produced significant
increases in withdrawal latency compared to the vehicle
injected (contralateral) paw. Withdrawal latencies at the
mid-plantar injected site reached cutoff (16 sec) during
week 1, the latencies then decreased by week 2 but
remained significantly different from contralateral paws
until they finally normalized by week 3 (Figure 2E).
Analgesia occurred with both doses of RTX and the
time course of recovery was similar but the effect,
however, was greater in the 50 ng group (p < 0.05).
Figure 2F and 2G directly compare behavioral responses
to the Aδ and C stimuli on day 18; after 50 ng RTX,
rats were generally unresponsive to the 5.12 W/mm
2 Aδ
stimulus (as compared to vehicle (p < 0.05). In contrast,
responses to the C stimulus were not significantly differ-
ent between the RTX and vehicle groups by day 18.
The mid-plantar hind paw is innervated by the tibial
nerve. Since the toes are also innervated by the tibial
nerve, we separately examined the effect of intraplantar
RTX on recovery kinetics in the toes. The probability of
withdrawal for the toes using the 5.12 W/mm
2 Aδ sti-
mulus was 0.72 ± 0.08 prior to RTX or vehicle treat-
ment, similar to that obtained with mid-plantar
stimulation. By 4 weeks, the probability of withdrawal
and the intensity rating were near maximal for the vehi-
cle-injected paw (0.94 ± 0.04 and 3.47 ± 0.16, respec-
tively) (Figure 3A and 3B). In contrast, on the RTX
injected side, the toe response was significantly reduced
for at least 7 weeks for the 5 ng group and 10 weeks for
the 50 ng group. Stimulation of the toes at higher inten-
sity (6.08 W/mm
2) resulted in higher baseline responses
(probability of withdrawal = 0.89 ± 0.05 and response
rating = 3.33 ± 0.21). Despite the stronger intensity, sig-
nificant reductions in behavioral responses mediated by
this Aδ stimulus could be seen for up to 7 weeks after
intraplantar RTX (Figure 3C and 3D). These data show
that behavioral sensitivity to Aδ stimuli is regained more
slowly in the toes compared to the mid-plantar injection
site. However, as with the mid-plantar site, analgesia in
the toe was significantly greater in the 50 ng as com-
pared to the 5 ng group (p < 0.001, Figure 3A and 3B;
p < 0.05, Figure 3C).
Responses to C stimuli at week 5 revealed a small but
significant difference between RTX (50 ng) and vehicle-
treated toes (Figure 3E). By 10 weeks, there was no dif-
ference. There was no measurable statistical difference
between the 5 ng RTX and vehicle-treated paws at week
5 or week 10.
Application of RTX initially evokes nociceptive activity
by binding to and activating TRPV1 [14]. This is fol-
lowed by a dying-back (axonopathy) of unmyelinated
and myelinated TRPV1-expressing fibers and potentially
a recruitment of macrophages that can release cytokines,
which in turn could activate the remaining proximal end
of the nerve fiber. Using RT-PCR, we examined the
DRG and spinal cord for expression of genes associated
with nociceptive activity and nerve regeneration after
RTX-treatment. As shown in Figure 4 the gene encod-
ing the nociceptive chemokine MCP-1 [34,35] was
increased in the DRG at 24 h, likely due to an initial
burst of nociceptive activity following TRPV1 activation
[36], but expression normalized by day 10 (Figure 4A-C).
Table 1 Latency to observable movement following short-pulse (100 ms), high intensity stimulation with infrared
diode laser (6.08 W/mm2)
Standing on 2 or 3 paws Standing on 4 paws Total
Total number of trials 8 8 16
Shortest latency to fLEM 56 ms 74 ms 56 ms
†Fastest conduction velocity 3.0 m/s 2.3 m/s 3.0 m/s
Mean latency to fLEM (± SEM) 159.5 ± 36.7 ms 250.0 ± 28.9 ms 204.8 ± 25.4
†Mean conduction velocity 1.1 m/s 0.7 m/s 0.8 m/s
Shortest latency to withdrawal of stimulated limb 74 ms 128 ms 74 ms
Mean latency to withdrawal of stimulated limb (± SEM) 213.0 ± 34.1 271.0 ± 27.7 242.0 ± 22.5
†Conduction velocities are likely a gross underestimation of the actual conduction velocities. They do not account for central delay (~80 ms in the rat) [32],
motoneuron conduction velocity (33-85 m/s) [33] or the time required for muscle contraction/relaxation (34-116 ms) [33]. Nonetheless, we were able to
demonstrate that it is possible to detect nocifensive behaviors that are temporally consistent with being mediated by Aδ-fibers. The posture of the animal before
stimulation appears to greatly influence our ability to detect movements with short or longer latencies.
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Page 4 of 13In contrast, the nerve regeneration marker ATF3 [37]
was induced at 24 h but the increase was maintained
through day 10 (Figure 4A, B and 4D). The regenera-
tion marker galanin was also increased at day 5 and
10 (Additional file 2). Upregulated c-Fos in the spinal
cord is also an early marker of nociception [38,39].
Consistent with the elevation in ganglionic MCP-1
transcripts, c-Fos protein levels increased early (6 h)
but reverted by 24 h (Figure 4E-I), indicating that
regeneration after RTX-induced axonopathy is devoid
of ongoing spontaneous nociceptive activity sufficient
to induce these markers.
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Figure 2 Effect of RTX on Aδ and C responses at the mid-plantar injection site. Either 5 or 50 ng of RTX was injected into the right while
vehicle was injected into the left hind paw. Aδ and C responses before and after injections were followed for several weeks. (A-D and F)A δ
responses following intraplantar RTX-injection. We used probability of withdrawal (A, C and F) and the intensity of withdrawal (B and D)a s
endpoints for the Aδ assay. Behavioral responses to stimulus intensities at 5.12 W/mm
2 (A, B and F) or 6.08 W/mm
2 (C and D) are shown. (E)
Loss and return of C-fiber responses after RTX-intraplantar injection. We used latency to paw withdrawal as the endpoint for the C-fiber assay; a
stimulus intensity was chosen that produced a response latency of ~8 sec in normal rats. A cutoff of 16 sec (dashed line) was imposed to
prevent tissue damage. (F and G) Direct comparison of behavioral responses at day 18 post-RTX to Aδ (F) and C (G) stimuli. Data used in week
3, in the line graphs, are the average of tests done on days 16, 18 and 21. Hypoalgesia at day 18 was maintained in Aδ but not C-fibers. The
tables under the graphs denote statistical comparisons between vehicle and 5 ng or 50 ng RTX, which are aligned with the post-treatment time
points. Each data point is an average of the combined responses from 2 or 3 non-consecutive days of testing during the time period indicated
on the x-axis (weeks). For graphical simplicity, the data from all vehicle-treated rats (n = 12) is combined, yielding a single line in the plots, since
there was no significant difference between the two vehicle groups. 2-way ANOVA with repeated measures was used to compare the effect of 5
ng or 50 ng RTX versus vehicle. 2-way ANOVA was used to compare the effects of 5 ng versus 50 ng. Fisher’s exact test was used in F.* , † p<
0.5, **,†† p < 0.01, ***, ††† p < 0.001, n = 6 rats per group.
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In the present study, we examined (a) behavioral
responses associated with thermal laser stimulation of
Aδ- and C-fibers in awake rats, (b) such behavioral
responses after peripheral ablation of the two fiber types
following intraplantar administration of the vanilloid
agonist RTX, (c) the time-course of recovery/regenera-
tion, and (d) the expression of markers for nociception
and nerve regeneration. The results demonstrate that
the infrared diode laser can be tuned to evoke beha-
vioral responses temporally consistent with activation of
Aδ-fibers in the rat hind paw. The results also
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Figure 3 Aδ- and C-fiber responses in the toes after mid-plantar RTX injection. The infrared diode laser was used to stimulate Aδ-o rC -
fibers in the toes of the same rats used in Figure 2. (A-D) Responses to Aδ stimuli are diminished for up to 10 weeks. Plots are similar to those
in Figure 2. (E) For 50 ng RTX only, a small but significant difference was measured in the toes at 5 weeks (but not at 10 weeks) for C responses;
data reported are an average of 3 test days. Our initial protocol used C-fiber testing only at the mid-plantar footpad; however, since we
observed prolonged, diminished Aδ behavioral responses in toes after RTX-treatment, a suppression of C-fiber behavioral responses might occur
in tandem. During a separate study, we found that within 1 week after 50 ng intraplantar RTX, rats reached the 16 sec cutoff when testing C-
fibers in their toes. 2-way ANOVA with repeated measures was used to compare the effect of 5 ng or 50 ng RTX versus vehicle. 2-way ANOVA
was used to compare the effects of 5 ng versus 50 ng. *,† p < 0.5, **,†† p < 0.01, ***,††† p < 0.001, n = 6 rats per group.
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both Aδ- and C-fiber mediated thermal sensations in
the footpad and toes. This is followed by a progressive
recovery of behavioral function from proximal (mid-
plantar) to distal (toes) over several weeks.
One of the main aims of the present report was to
evaluate infrared laser evoked Aδ- and C-fiber nocifen-
sive behaviors. Two approaches were used: analysis of
behavioral reactions in the immediate 300 msec of the
post-stimulus period and modulation of behaviors fol-
lowing intraplantar injection of RTX. We first estab-
lished, with high-speed videography, that nocifensive
behaviors following short duration (100 msec), high-
intensity laser pulse stimulation (6.08 W/mm
2)a r e
mediated by Aδ-fibers, consistent with reported electro-
physiological [24,25] and laser-evoked potential
[22,26,40,41] observations. Importantly, the latency to
withdrawal of the stimulated limb was not always useful
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Figure 4 Intraplantar injection of RTX leads to a transient increase in gene markers of nociception but a sustained increase in markers
of nerve regeneration. Gel image shows ganglionic expression levels of mRNA encoding MCP-1 and ATF3 24 h or 10 days after vehicle or RTX
treatment, taken from left and right L4-L5 dorsal root ganglia (n = 4 rats, ipsilateral RTX expression is denoted by an asterisk). MCP-1 (C) and
ATF3 (D) transcript levels were normalized to GPDH. Data were obtained from RT-PCR analysis (n = 4/group). All graphs are presented as mean
± SEM. *p < 0.05 and **p < 0.01, and ***p < 0.001 as determined by a one-way ANOVA followed by a Bonferroni correction. (E-H)
Immunohistochemistry showing spinal cord c-Fos expression 6 h or 10 d post-RTX. E and F are epifluorescent images depicting an elevation in
c-Fos protein 6 h after RTX or vehicle in the ipsilateral and contralateral dorsal horn, respectively. G and H are epifluorescent images
representing c-Fos expression 10 d after RTX or vehicle in the ipsilateral and contralateral dorsal horn, respectively. (I) Cell counts demonstrate
significantly more c-Fos immunopositive cells in spinal cord ipsilateral to RTX injection as compared to contralateral vehicle injections at 6 h but
not at 24 h or 10 days. Data expressed as means ± SEM (n = 4). The fold-change is shown. *p < 0.05 as determined by Student’s t-test. Arrows
indicate the location of the medial dorsal horn. The most intense c-Fos positive neurons were counted in this area.
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Page 7 of 13for estimating the conduction velocities of activated
fibers. Instead, by capturing the behavior of the entire
animal with a high-speed camera, we often observed
that a rapid set of movements occurs before withdrawal
of the stimulated limb. In most cases the latencies of
these early movements indicated a faster afferent con-
duction velocity than if the latency to withdrawal of the
stimulated limb was used as the endpoint. The progres-
sion of motion after the first observable laser-evoked
movement (fLEM) was often consistent with postural
adjustments to ensure stability that preceded a later, yet
brisk, withdrawal of the stimulated limb. The shortest
latency to fLEM was 56 ms, yielding a conduction velo-
city estimate for the primary afferent volley of 3 m/s,
which is in the range for Aδ fibers and well above the
r a n g ef o rC - f i b e r s .I nap r e v i o u ss t u d yu s i n gaC O 2
laser, EMG recordings taken from the gluteus maximus
and biceps femoris of the stimulated limb yielded evoked
electrical activity at ~280 ms [26]. However, these studies
were performed on anesthetized animals whereas the
present observations, obtained from awake unrestrained
rats, suggest that complex postural changes and even
reflexive Aδ-type behaviors are suppressed when the ani-
mal is under anesthesia. Our high speed imaging of the
earliest, reflex-like movements is indicative of an Aδ-
mediated nociceptive response to ‘first pain’ [42] and an
activation of the Aδ “alarm system” [43].
When rats supported their body weight on 2 or 3
paws, fLEM often occurred at < 160 ms and frequently
the movement occurred on the contralateral (i.e., unsti-
mulated) side. This suggests that a readily observable
short latency Aδ-evoked movement is more likely to be
revealed when rats are in a “reared” position, or any
posture that opportunistically requires rapid mediolat-
eral balance adjustment prior to paw withdrawal. In
contrast, when rats are standing with body weight dis-
tributed to all four legs, and therefore more neutrally
balanced, latency to fLEM increased to ~250 msec.
When all four paws are on the ground, early postural
adjustments are difficult to detect if they primarily
involve the axial musculature rather than repositioning
of the forepaws or head and neck, all of which can
occur in the first 100 msec following the end of the
laser pulse. An additional consideration is that in the
rat, central delay to acute laser stimulation has been
reported to last for up to 80 ms [32]. Whether this
makes a significant contribution to “preparatory” adjust-
ments [44] or long latency movements is being further
investigated but it is clear that controlled balance at the
moment of retraction of the stimulated paw is a priority
for spinal sensory-motor circuits (for an example in
humans, see [45]).
The actions of RTX are manifested in both Aδ-a n d
C-fiber types. We observe that peripherally administered
RTX temporarily eliminates behavioral responses to
both Aδ- and C-fiber mediated thermal nociception.
Our data corroborate previous human studies in which,
after prolonged capsaicin treatment, cortical LEPs corre-
sponding to activated Aδ- and C-fibers are eliminated,
as well as the behavioral response [46,47]. The capacity
to independently test the two fiber types using our cur-
rent laser settings suggest differential recovery rate for
Aδ compared to C-fibers. After administering the higher
dose of RTX (50 ng), responses to the C-fiber stimulus
recovered first, but responses to the Aδ stimulus lagged
by several weeks. However, the C-fiber stimuli also cov-
ered a greater area of skin, increasing the likelihood of
activating a functional nerve ending. In both cases,
responses to the C-fiber and Aδ stimuli, which were
initially eliminated, returned gradually rather than
abruptly. The gradual return is consistent with the idea
that, within a single fiber type, the rate of regeneration
is heterogeneous. It is also possible that, during recov-
ery, C-fibers played a more pronounced role in mediat-
ing behavioral responses as they were no longer
preempted by the faster Aδ input [48]. The lag in recov-
ery of the full, archetypal Aδ behavioral responses after
RTX may indicate that the Aδ-fibers are greatly com-
promised and/or undergo a more extensive axonopathy
and/or that return of function depends on complete re-
myelination. Because the diameter of the Aδ laser spot
was small we could stimulate multiple discrete areas of
skin and spatially map the thermal sensitivity of the
paw. Spatial mapping of the paw demonstrated a slower
return of distal sensitivity (toes) compared to return of
sensitivity proximal to the injection site (mid-plantar).
Therapeutically, prolonged behavioral recovery at sites
distal to an RTX injection indicates that regional analge-
sia can be sustained longer by injecting RTX more prox-
imal to the DRG and has potential therapeutic
ramifications for treatment of peripheral neuropathic
pain problems subsequent to nerve injury or possibly
chemotherapy.
During the first 3 to 5 weeks of repeated testing, we
observed that the rats became progressively more sensi-
tive to the Aδ stimulus (Figure 2 and 3). This may be
due to one or more concurrent processes, including (a)
cued or non-cued learning or anticipation, which may
be greatly influenced by the aversive nature of the sti-
mulus, and (b) habituation to the novelty of the testing
environment. Interestingly, the rats did not become
more sensitive to C-fiber stimuli over the course of the
study. This likely reflects a specific difference between
the C and Aδ stimuli. Our C-fiber test involves slow-
rate heating over several seconds (average latency ~8 sec)
and the sensation of warming occurs well before the
stimulus becomes noxious. Even if distracted by environ-
mental cues, the warming phase can act as a thermal cue
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rats maintained consistent withdrawal latency to C-fiber
stimuli and did not exhibit a trend towards shorter laten-
cies after repeated testing. This suggests that neither
learning or anticipatory cues nor habituation critically
affect responses in longitudinal C-fiber testing. In con-
trast, the sharp, pricking sensation of an Aδ stimulus
(as reported by human subjects, [49]) may make it
substantially more aversivet h a naC - f i b e rs t i m u l u sa n d
t h e r e f o r ec o u p l ei tm o r et i g h t ly to anticipatory or learn-
ing circuits and suggest that further exploration of these
aspects is warranted.
The initial RTX-induced nociceptive phase, subse-
quent analgesia, and nerve regeneration were each dis-
cernible at the molecular level. We assessed the
temporal regulation of several molecular markers of
nociceptive and regenerative processes in DRG or spinal
cord following intraplantar injection of RTX. MCP-1 is
widely thought to be a marker of pain since transcript
and protein levels are upregulated in the DRG by per-
ipheral inflammation [36] and in neuropathic pain mod-
els [50-52]. With intraplantar RTX, we observed that
ganglionic MCP-1 was induced at 24 h, consistent with
our previous findings [36]. T h ei n c r e a s ei nM C P - 1w a s
not sustained: no elevation was detected at day 5 (data
not shown) or at day 10. In contrast, ATF3, a marker of
nerve regeneration [37,53], exhibited an increase at 24 h
that was sustained at both day 5 and 10, indicative of a
long-lasting regenerative process after intraplantar injec-
tion of RTX. Strong upregulation of galanin, another
marker of nerve regeneration, was also detected on day
5 and 10. Cumulatively these data suggest that processes
involved in peripheral nerve regeneration do not contri-
bute to the maintenance of MCP-1 upregulation.
Further investigation may provide clues to the mechan-
isms of MCP-1 upregulation in neuropathic and inflam-
matory models of pain and the heterogeneity of
neuronal expression in the DRG. At least in the case of
RTX, action potentials or calcium signaling [12] may be
involved, since RTX induces acute, prolonged nocicep-
tive behaviors at the 50 ng dose [36] and a massive
influx of calcium [13] precedes desensitization. It is also
possible, however, that MCP-1 is induced by the initial
dying back of the TRPV1-expressing fibers (e.g., due to
a loss of trophic factor signaling) rather than the initial
burst of nociceptive activity. Consistent with the transi-
ent increase in MCP-1 following peripheral RTX, we
observed that expression of the c-fos gene, measured by
c-Fos protein immunostaining, was transiently increased
in the spinal cord immediately after intraplantar RTX
injection, consistent with our previous findings [17].
Induction of c-Fos in the spinal cord is widely accepted
as a marker of pain signaling [38,39]. A drop in c-fos
gene expression towards baseline levels by 24 h further
indicates that RTX induces an immediate inactivation of
nerve fibers since sustained nociceptive input can pro-
duce a long-lasting change in Fos proteins in dorsal
spinal cord [38]. The lack of sustained elevation in pro-
tein occurs concurrently with a pronounced behavioral
analgesia.
Conclusion
Together our data demonstrate that analgesia following
intraplantar administered RTX lasts much longer than
previously assumed. The previous underestimate is due,
in part, to the undetected extended time required for
complete behavioral recovery to an Aδ stimulus. High-
speed videography suggests that Aδ nociception engages
a complex process of rapid sensory-motor integration
involving coordinated postural and balance adjustments
prior to limb retraction. Infrared laser stimulation in
awake, unrestrained animals can be used to assess the
behavioral role of Aδ-fibers in several pain models and
to differentiate mechanisms related to myelinated and
non-myelinated fiber populations.
Methods
Animals
Male Sprague-Dawley rats (250-350 g) were housed
under a 12 hr light-dark cycle and allowed access to
food and water ad libitum. The ambient temperature of
the holding and testing rooms was 21-22°C. Procedures
were performed in accordance with the National Insti-
tutes of Health (NIH) Guidelines for the Care and Use
of Laboratory Animals, and approved by the National
Institute of Dental and Craniofacial Research (NIDCR)
Animal Care and Use Committee. All efforts were made
to minimize both animal numbers and distress within
the experiments.
RTX administration
Sealed glass ampoules of RTX (1 mg) were obtained
from LC Laboratories (Woburn, MA). RTX was solubi-
lized in 150 μl ice-cold 100% ethanol, diluted with 50 μl
ddH2O supplemented with ascorbic acid (to make a
final RTX stock concentration of 5 μg/μlR T Xa n d
2 mM ascorbic acid), and further diluted to a working
concentration of 100 ng/μl in sterile vehicle (0.25%
Tween-80, 2 mM ascorbic acid, 0.9% NaCl). Vehicle was
also used to dilute RTX (100 ng/μl) to lower working
concentrations. All intraplantar injections were made
using a total volume of 50 μl.
Thermal stimulus paradigm
An infrared diode laser (LASS-10 M; Lasmed, LLC,
Mountain View, CA) with an output wavelength of 980
nm and maximum power of 20 W was used to generate
thermal stimuli. For calibration, laser power/energy was
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L30A-10 MM, Ophir Optronics). Cutaneous C-fibers
were selectively activated by low-rate heating using long
pulses, low energy and a large diameter beam (5 mm Ø,
nominal) [24]. Aδ-fibers were selectively activated with a
high rate of heating, using a high-energy, brief pulse
(100 ms), and a small spot size (1.6 mm Ø, nominal). A
thermal damage cutoff for each stimulus paradigm was
determined primarily by visual examination (e.g., pre-
sence of a spot of protein coagulation, acute redness or
blistering, swelling 24 h post) of stimulated, anesthetized
rats. We observed that Aδ pulses at 7000 mA (corre-
sponding to a power density of 6.93 W/mm
2)o f t e n
resulted in instantaneous skin damage whereas 6000
mA (6.08 W/mm
2), which evokes strong behavioral
withdrawal responses, never produced visible skin
damage. The skin heating rate for each Aδ stimulus was
measured with an infrared camera (ThermoVision
SC6000, FLIR Systems, Inc.) on the plantar foot pad of
anesthetized rats, acquired at 400 fps. At 5000 mA (5.12
W/mm
2) the rate was ~235°C/sec; at 6000 mA (6.08 W/
mm
2) the rate was ~300°C/sec. For the C-fiber stimulus
(1000 mA; 0.083 W/mm
2), a 16 sec cutoff was used
since visible skin damage was not detected in stimulated
paws within 24 h. Stimulation for 18 sec, on the other
hand, resulted in visible skin damage. Generally, latency
to paw withdrawal is ~8 sec with our C stimulus
parameters.
Behavioral testing
The testing paradigm is similar to an earlier protocol
that we established using a radiant heat stimulus from a
focused incandescent light source [54]. Rats were placed
unrestrained under plastic enclosures on an elevated
glass platform. The enclosures (23 × 13 × 13 cm) were
l a r g ee n o u g hf o rt h er a t st om o v ef r e e l y .R a t sr e q u i r e d
5-10 min to habituate. The laser collimator was attached
to a support and positioned below the glass, with the
beam perpendicular to the surface. Great care was taken
to keep the glass surface dry and free of debris or
excrement.
The endpoint for C-fiber response is paw withdrawal
latency. In this case, when the rat was still with paw flat
on glass, the beam was aimed at the mid-plantar foot pad
then fired continuously until withdrawal. The latency to
withdrawal was measured by the experimenter using a
digital stopwatch. Preliminary studies determined that
typical basal withdrawal latencies for adult Sprague-
Dawley rats (250-350 g) subjected to a 0.083 W/mm
2
stimulus was between 8-9 sec, similar to the latency
obtained with a white-light radiant heat stimulus [54].
T h er e s p o n s et oah i g h - e n e r g yA δ stimulus in
untreated, normal rats is brisk and behaviorally produc-
tive, characterized by rapid paw withdrawal, orientation
of the head to the stimulated paw, and paw shaking and
licking, which is similar to that observed when using a
CO2 laser [28,55]. Since withdrawal latency was gener-
ally too rapid to be an informative endpoint for the Aδ
response, we instead used a binary measure (no withdra-
wal = 0, withdrawal = 1), and calculated the probability
of withdrawal to each stimulus intensity (total withdra-
wals/total number of trials). Rats, 3 to 4 at a time, were
placed on an elevated glass test platform and stimulated
sequentially; the inter-stimulus interval, per rat, was
typically ~1 min. Two different stimuli were used where
the lower stimulus intensity (5.12 W/mm
2)a l w a y sp r e -
ceded testing of the higher intensity (6.08 W/mm
2).
Mid-plantar site was stimulated on each rat and then
the toe on each rat. On any one test day, two different
spots on the mid-plantar region were stimulated, one
with 5.12 and the other with 6.08 W/mm
2; also two dif-
ferent toes were stimulated: the index toe received 5.12
W/mm
2 and the middle toe received 6.08 W/mm
2, for a
total of 4 stimuli per rat per day unless noted otherwise.
Responses to C-fiber stimuli (mid-plantar) were deter-
mined at least 10 min after evaluation of Aδ responses.
Only one C-fiber test was administered per day. When
C-fiber responses were tested on toes, the same spot dia-
meter of 5 mm was used. The toes in these rats are at
least 5 mm long but 2 mm wide. The stimulus was
applied in such a way as to ensure that an area of 5 ×
2 mm was heated. Aδ responses were not determined on
days when the toes were stimulated with the C-fiber sti-
mulus. To assess the effects of RTX, responses from each
animal (n = 6) were grouped according to stimulation
site (mid-plantar or toe) and stimulus intensity (5.12 or
6.08 W/mm
2). Responses from 2 or three test days dur-
ing the indicated time period (weeks) were pooled and
averaged to obtain mean response values. To determine
statistical significance, repeated measures 2-way ANOVA
was used where responses were compared between vehi-
cle- and RTX-treated paws in each animal.
A subjective rating scale for behavioral intensity was
also developed to compare the effect of RTX on with-
drawal responses. There was nearly complete concur-
rence on the rating in all tests when performed
independently (JMK, KM, MJI or BDB). The categories
were: 0 = no visible response; 1 = slight twitch of the
body or abrupt movement of head; 2 = withdrawal of
the foot off the glass, including either a rapid return of
the paw to the glass as well as the rat walking away; 3 =
withdrawal of the foot characterized by prolonged paw
shaking or guarding, and orientation of the head, with-
out licking; 4 = strong withdrawal, which includes paw
shaking, orientation and licking. Although this endpoint
was useful in characterizing the degree of the nocifen-
sive behavior associated with Aδ stimulation, we cannot
say for certain whether licking, which sometimes
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fibers, C-fibers or both.
High-Speed Videography
A high-speed 12-bit monochrome camera (AOS Tech-
nologies AG, Switzerland) was used to precisely capture
rapid movements associated with withdrawal activity.
Images were acquired at 500 frames per second and
recorded for a total of 2 sec, which was sufficient to
capture the entire 100 ms laser pulse (IR light appears
as a saturating flash for 50 frames) and withdrawal of
the stimulated limb. Rats used for recording were initi-
ally conditioned to the test for 3 days prior (not conse-
cutive). Many preliminary recordings (> 40) of
stimulated rats were taken to determine the best condi-
tions, by varying such factors as the viewing angle and
illumination. Although ultimately not all were used for
the data in Table 1 they were constructive to developing
our hypothesis. In some recordings, to better view the
musculature, fur on rats hind quarters was shaved off to
reveal the lower back, hips, and legs. Great care was
taken to only record when the rats were properly habi-
tuated and sitting still at the moment of stimulation,
irrespective of posture. For the data presented in
Table 1, 4 rats total were used, and the middle or index
toe was targeted with the 100 ms, 6.08 W/mm
2 stimu-
lus. On each day (2 total) of video recording, only one
stimulation was performed on both the left and right
toes, totaling 8 trials/day. The index toe was used on
one day while the middle was used for the second. For
calculating latency to withdrawal, frames were counted
from the onset of laser stimulation to the onset of the
first-observable movement or muscle twitch. In separate
experiments, these rats were also stimulated at the same
laser intensity but with progressively shorter pulse dura-
tions (increments of 10 ms) to determine the minimum
time required to initiate a response. Stimulation for
30 ms did not evoke withdrawal responses (0/8) whereas
stimulation for 40 ms evoked withdrawal in 25% of the
trials (2/8). Thus, when determining the latency, 30 ms
was subtracted from the total time, since the fibers were
not sufficiently heated by 30 ms to initiate a response.
Therefore the noxious phase of the 6.08 W/mm
2 stimu-
lus was defined as the last 70 of 100 ms. An estimation
of the conduction velocity was then calculated using the
length of the exposed nerve, by gross dissection, from
the toe to the lamina 5 dorsal root entry zone.
Immunofluorescence and cell counting
Immunohistochemistry was performed on 12 μmf r e s h
frozen sections, which were immersion fixed for 10 min
in 4% buffered formaldehyde at room temperature and
subjected to antigen retrieval by boiling (20 min) in tar-
get retrieval solution, high pH (DAKO, Glostrup,
Denmark). The primary antibody was a rabbit anti-rat
c-fos [56] diluted 1:10 K. For immunofluorescence stain-
ing, secondary antibodies conjugated with Alexa Fluor
488 (Invitrogen) was used. Images were obtained with
an epifluorescence microscope attached to CCD camera
(Olympus) using Olympus software to take images of all
samples under the same exposure time. For cell count-
ing, an immunofluorescence intensity cut-off was estab-
lished to eliminate counting of basally expressed c-Fos
in the medial portion of the spinal cord.
RT-PCR Analysis
RTX (50 ng) was injected into one paw and vehicle was
injected into the contralateral paw. Animals were sacri-
ficed 6, 24, 120 or 240 h later, dorsal root ganglia were
removed and RNA was extracted as previously described
[57]. RT-PCR was performed using the Access RT-PCR
s y s t e m( P r o m e g a ,M a d i s o n ,W I ) .T h eP C Rp r i m e rp a i r s
are 5’-CTGTGGTTTTTGGTGGGAAG-3’ and 5’-
GGCCATGTAAACTGGCTGAT-3’ for ATF-3 (250 bp);
5’-CCAGAAACCAGCCAACTCTC-3’and 5’-CCGACT-
CATTGGGATCATCT-3’ for MCP-1 (192 bp);
5’-ACCACAGTCCATGCCATCAC-3’ and 5’-TCCAC-
CACCCTGTTGCTGTA-3’ for GPDH (452 bp). The
RT-PCR analysis was performed according to the manu-
facturer’s instruction in 25 μL reaction mixture contain-
ing exactly 8 ng of RNA. RT-PCR steps were 1 cycle of
45 min at 45°C for reverse transcription, 1 cycle of 2 min
at 94°C for inactivation of transcriptase, 26-30 cycles of
30 s at 94°C for denaturation, 1 min at 55°C for anneal-
ing, 2 min at 68°C for extension, and final extension at
68°C for 7 min. The RT-PCR products were separated by
electrophoresis on 2% agarose/ethidium bromide gels
and images were acquired with an AlphaImager system
(Alpha Innotech Corp.). The relative intensities of the
RT-PCR products, as visualized on the gel, were analyzed
quantitatively using ImageQuant 5 software. The results
were normalized to GPDH. Comparisons of gene expres-
sion from ipsilateral and contralateral tissues were made
by paired Student’s t-test.
Additional material
Additional file 1: Aδ laser stimulation of rat hind paw captured with
high-speed videography. The rat was recorded at a rate of 500 frames
per sec (fps) to capture the first-observable movement after laser
stimulation (6.08 W/mm
2). The laser stimulus (100 ms, 31 frames) can be
easily observed since infrared light saturates the CCD sensor, appearing
as black pixels in the video. The rat was at rest and motionless
immediately before stimulation. Post-stimulation, ostensible movement
could be detected in the left forearm and the right shoulder by 104 ms.
Clear movement of the contralateral paw could be detected by 4 frames
(113 ms). Complete limb withdrawal and paw licking occur several
frames later. The total length of the recording is 1 sec. Withdrawal of the
stimulated limb appears rapid and very brisk when viewed in real-time.
[Note: Due to video compression, this reformatted video file plays at
~310 fps.]
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Page 11 of 13Additional file 2: Upregulation of galanin following intraplantar
injection of RTX (50 ng). Gel image shows ganglionic expression levels
of mRNA encoding galanin 5 or 10 days (A and B, respectively) after
vehicle or RTX treatment, taken from left and right L4-L5 dorsal root
ganglia (n = 4 rats, ipsilateral RTX expression is denoted by an asterisk).
Graph in (C) shows that galanin transcript levels (after GPDH
normalization) were significantly altered by intraplantar RTX injection.
Graph is presented as mean ± SEM. (N = 4/group). ***P < 0.001 as
determined by one-way ANOVA followed by a Bonferroni correction.
ATF3 transcript levels were also increased on day 5 whereas MCP-1 levels
were not (data not shown).
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